Concepedia

Publication | Open Access

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

DOIFull Paper Access

177

Citations

29

References

2007

Year

Mark A. Deeg, John B. Buse, Ronald Goldberg, David M. Kendall, Anthony J. Zagar, Scott J. Jacober, Mehmood Khan, Alfonzo T. Perez, Meng H. Tan
Diabetes Care

Abstract

PIO and ROSI treatments have different effects on serum lipoprotein subclass particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

References

YearCitations

Page 1